FREQUENCY OF CARDIAC AUTONOMIC NEUROPATHY IN TYPE 2 DIABETES MELLITUS PATIENTS PRESENTING TO KHYBER TEACHING HOSPITAL PESHAWAR

M SAMI; . SANA

doi:10.54112/bcsrj.v2023i1.466

Authors

M SAMI Department of Medicine, Khyber Teaching Hospital Peshawar, Pakistan.
. SANA Department of Endocrinology, Hayatabad Medical Complex Peshawar, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.466

Keywords:

Cardiac Autonomic Neuropathy, Type 2 Diabetes Mellitus,, Cardiac Autonomic Dysfunction

Abstract

This study aimed to determine the frequency of cardiac autonomic neuropathy in patients with type 2 diabetes. A cross-sectional study was conducted at the Department of Medicine, Khyber Teaching Hospital Peshawar, Pakistan, from June 2022 to June 2023. The study included 285 individuals aged 40-60 diagnosed with type 2 diabetes for at least 5 to 10 years. The study aimed to evaluate the frequency of cardiac autonomic neuropathy in type 2 diabetics. Chi-square was applied for statistical analysis with a significance level of p≤0.05. Of 285 type 2 diabetic patients, 199 (69.82%) were male, and 86 (30.18%) were female. 26.31% of the participants were diagnosed with cardiac autonomic neuropathy, of which 26.67% were male and 73.33% were female. This difference was statistically significant. 37.35% of the patients with cardiac autonomic neuropathy were smokers, while 62.65% were non-smokers. All the patients with CAN were either overweight or obese. This study found that prolonged diabetes is directly related to the development of cardiac autonomic neuropathy, and there was a statistically significant association between diabetes and gender, as well as smoking.

Downloads

Download data is not yet available.

References

Aamir, A. H., Ul-Haq, Z., Fazid, S., Shah, B. H., Raza, A., Jawa, A., Mahar, S. A., Ahmad, I., Qureshi, F. M., & Heald, A. H. (2020). Type 2 diabetes prevalence in Pakistan: what is driving this? Clues from subgroup analysis of normal weight individuals in diabetes prevalence survey of Pakistan. Cardiovascular endocrinology & metabolism, 9(4), 159–164.

Akhtar, S., Nasir, J. A., Abbas, T., & Sarwar, A. (2019). Diabetes in Pakistan: A systematic review and meta-analysis. Pakistan journal of medical sciences, 35(4), 1173–1178

American Diabetes Association (2018). 10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2018. Diabetes care, 41(Suppl 1), S105–S118.

Bhuyan, A. K., Baro, A., Sarma, D., & Choudhury, B. (2019). A Study of Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus: A Northeast India Experience. Indian journal of endocrinology and metabolism, 23(2), 246–250.

Birajdar, SV., Chavan, SS., Munde, SA., Bende, YP. (2017) A study of autonomic nervous system dysfunction among patient with diabetes mellitus: a cross sectional study. International Journal of Advance Medicine, 4, 406-411.

Bissinger A. (2017). Cardiac Autonomic Neuropathy: Why Should Cardiologists Care about That?. Journal of diabetes research, 2017, 5374176.

Breder, I. S. S., & Sposito, A. C. (2019). Cardiovascular autonomic neuropathy in type 2 diabetic patients. Revista da Associacao Medica Brasileira (1992), 65(1), 56–60.

Chowdhury, M., Nevitt, S., Eleftheriadou, A., Kanagala, P., Esa, H., Cuthbertson, D. J., Tahrani, A., & Alam, U. (2021). Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis. BMJ Open Diabetes Research and Care, 9(2), e002480.

Dhumad, M.M., Hamdan, F.B., Khudhair, M.S., Al-Matubsi, H.Y. (2021). Correlation of staging and risk factors with cardiovascular autonomic neuropathy in patients with type II diabetes mellitus. Sci Rep 11, 3576

Hu F. B. (2011). Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes care, 34(6), 1249–1257.

John, A. P. P., Udupa, K., Avangapur, S., Sujan, M. U., Inbaraj, G., Vasuki, P. P., Mahadevan, A., Anilkumar, R., Shekar, M. A., & Sathyaprabha, T. N. (2022). Cardiac autonomic dysfunctions in type 2 diabetes mellitus: an investigative study with heart rate variability measures. American journal of cardiovascular disease, 12(4), 224–232.

Liao, D., Sloan, R. P., Cascio, W. E., Folsom, A. R., Liese, A. D., Evans, G. W., Cai, J., & Sharrett, A. R. (1998). Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes care, 21(12), 2116–2122.

Menon, A. S., Dixit, A., Garg, M. K., & Girish, R. (2017). Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus at High Risk for Foot Ulcers. Indian journal of endocrinology and metabolism, 21(2), 282–285.

Meo, S. A., Zia, I., Bukhari, I. A., & Arain, S. A. (2016). Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast. JPMA. The Journal of the Pakistan Medical Association, 66(12), 1637–1642

Moţăţăianu, A., Maier, S., Bajko, Z. Voidazan, S., Bălaşa, R., & Stoian, A. (2018) Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients. BMC Neurology. 18, 126.

Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017). IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice, 128, 40–50.

Pan, Q., Li, Q., Deng, W., Zhao, D., Qi, L., Huang, W., Ma, L., Li, H., Li, Y., Lyu, X., Wang, A., Yao, H., Xing, X., & Guo, L. (2018). Prevalence of and Risk Factors for Peripheral Neuropathy in Chinese Patients With Diabetes: A Multicenter Cross-Sectional Study. Frontiers in endocrinology, 9, 617.

Pathak, A., Gupta, S., Kumar, S. & Agrawal, S. (2017). Evaluation of cardiovascular autonomic nervous functions in diabetics: study in a rural teaching hospital. Journal of Practice of Cardiovascular Sciences.3, 150–157.

Phurpa., Ferdousi S. (2017). Evaluation of autonomic dysfunction by heart rate variability analysis in type 2 diabetes mellitus. Asian Journal of Pharmaceutical and Clinical Research, 10(1), 309-312.

Pop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., & Action to Control Cardiovascular Risk in Diabetes Study Group (2010). Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes care, 33(7), 1578–1584.

Shah, A. S., El Ghormli, L., Vajravelu, M. E., Bacha, F., Farrell, R. M., Gidding, S. S., Levitt Katz, L. E., Tryggestad, J. B., White, N. H., & Urbina, E. M. (2019). Heart Rate Variability and Cardiac Autonomic Dysfunction: Prevalence, Risk Factors, and Relationship to Arterial Stiffness in the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes care, 42(11), 2143–2150.

Williams, S. M., Eleftheriadou, A., Alam, U., Cuthbertson, D. J., & Wilding, J. P. H. (2019). Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review. Diabetes therapy : research, treatment and education of diabetes and related disorders, 10(6), 1995–2021.

Williams, S., Raheim, S. A., Khan, M. I., Rubab, U., Kanagala, P., Zhao, S. S., Marshall, A., Brown, E., & Alam, U. (2022). Cardiac Autonomic Neuropathy in Type 1 and 2 Diabetes: Epidemiology, Pathophysiology, and Management. Clinical therapeutics, 44(10), 1394–1416.

Witte, D. R., Tesfaye, S., Chaturvedi, N., Eaton, S. E., Kempler, P., Fuller, J. H., & EURODIAB Prospective Complications Study Group (2005). Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia, 48(1), 164–171.